A phase 2, open-label study of pan-genotype regimen of SH229 plus daclatasvir in Chinese patients with chronic hepatitis C virus infection

Rui Hua, Junqi Niu, Guangming Li et al.|Journal of Hepatology|2020

Cited by 1